- Type / Class
- Equity / Common Stock
- Shares outstanding
- 28,736,767
- Total 13F shares
- 30,993,264
- Share change
- +711,831
- Total reported value
- $4,027,744,892
- Put/Call ratio
- 108%
- Price per share
- $130.06
- Number of holders
- 284
- Value change
- +$108,144,670
- Number of buys
- 141
- Number of sells
- 140
Quarterly Holders Quick Answers
What is CUSIP 81663L200?
CUSIP 81663L200 identifies WGS - GeneDx Holdings Corp. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 81663L200:
Top shareholders of WGS - GeneDx Holdings Corp. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| CMLS Holdings LLC |
13D/G
|
Keith A. Meister |
12%
|
3,630,826
|
$375,826,799 | -$48,159,994 | 22 Aug 2025 | |
| Casdin Capital, LLC |
3/4/5
13F
|
Director, 10%+ Owner · Company |
11%
|
3,027,682
|
$365,701,673 | -$60,451,950 | 22 Aug 2025 | |
| Eli Casdin |
3/4/5
|
Director, 10%+ Owner |
14%
|
3,880,073
|
$337,217,143 | — | 18 Jun 2025 | |
| Corvex Management LP |
13F
3/4/5
|
Company · Director, 10%+ Owner |
11%
|
3,058,629
|
$329,536,688 | — | 30 Sep 2025 | |
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI |
3/4/5
13D/G
|
10%+ Owner |
4.9%
from 13D/G
|
2,719,692
|
$192,487,561 | — | 15 Nov 2024 | |
| BlackRock, Inc. |
13F
|
Company |
5.3%
|
1,529,075
|
$164,742,539 | — | 30 Sep 2025 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13D/G
13F
|
Company |
4.3%
|
1,235,681
|
$133,132,271 | -$42,634,981 | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.1%
|
1,170,422
|
$126,101,267 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
13D/G
|
Company · THE GOLDMAN SACHS GROUP, INC. |
3.9%
from 13D/G
|
1,168,180
|
$125,859,714 | — | 30 Sep 2025 | |
| ORACLE INVESTMENT MANAGEMENT INC |
13F
|
Company |
3.1%
|
889,954
|
$95,883,644 | — | 30 Sep 2025 | |
| OPKO HEALTH, INC. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,646,972
|
$91,295,123 | — | 15 Aug 2024 | |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC |
13F
13D/G
|
Company |
3%
from 13D/G
|
823,567
|
$88,731,109 | — | 30 Sep 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
2.5%
|
718,003
|
$77,358,000 | — | 30 Sep 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
2.4%
|
681,381
|
$73,411,935 | — | 30 Sep 2025 | |
| Zweig-DiMenna Associates LLC |
13F
|
Company |
2.1%
|
602,300
|
$64,891,802 | — | 30 Sep 2025 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
2.1%
|
598,426
|
$64,474,418 | — | 30 Sep 2025 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
1.9%
|
544,094
|
$58,620,688 | — | 30 Sep 2025 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
1.8%
|
525,377
|
$56,604,000 | — | 30 Sep 2025 | |
| FMR LLC |
13F
13D/G
|
Company |
0.6%
from 13D/G
|
503,309
|
$54,226,598 | — | 30 Sep 2025 | |
| Invesco Ltd. |
13F
|
Company |
1.7%
|
494,072
|
$53,231,317 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
489,397
|
$52,735,613 | — | 30 Sep 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
1.7%
|
475,543
|
$51,235,002 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.6%
|
467,812
|
$50,402,119 | — | 30 Sep 2025 | |
| ARK Investment Management LLC |
13F
|
Company |
1.6%
|
446,979
|
$48,157,485 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.5%
|
439,806
|
$47,384,698 | — | 30 Sep 2025 | |
| Pentwater Capital Management LP |
13F
|
Company |
1.5%
|
425,000
|
$45,789,500 | — | 30 Sep 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.4%
|
410,030
|
$44,176,632 | — | 30 Sep 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.4%
|
395,731
|
$42,636,058 | — | 30 Sep 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.3%
|
360,063
|
$38,793,188 | — | 30 Sep 2025 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
357,302
|
$38,495,717 | — | 30 Sep 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
—
mixed-class rows
|
575,188
mixed-class rows
|
$35,732,000 | — | 30 Sep 2025 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
1%
|
292,255
|
$31,487,554 | — | 30 Sep 2025 | |
| Amova Asset Management Americas, Inc. |
13F
|
Company |
1%
|
292,255
|
$31,443,715 | — | 30 Sep 2025 | |
| Joshua Ruch |
3/4/5
|
Director |
0.65%
|
185,990
|
$29,229,921 | -$6,093,967 | 24 Nov 2025 | |
| GAGNON SECURITIES LLC |
13F
|
Company |
0.94%
|
269,066
|
$28,989,171 | — | 30 Sep 2025 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.94%
|
269,040
|
$28,986,000 | — | 30 Sep 2025 | |
| NEXT CENTURY GROWTH INVESTORS LLC |
13F
|
Company |
0.81%
|
234,109
|
$25,222,903 | — | 30 Sep 2025 | |
| Science & Technology Partners, L.P. |
13F
|
Company |
0.78%
|
224,073
|
$24,141,625 | — | 30 Sep 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.73%
|
209,255
|
$22,545,134 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.72%
|
206,461
|
$22,244,109 | — | 30 Sep 2025 | |
| Alamea Verwaltungs GmbH |
13F
|
Company |
0.68%
|
195,988
|
$21,115,747 | — | 30 Sep 2025 | |
| OBERWEIS ASSET MANAGEMENT INC/ |
13F
|
Company |
0.67%
|
193,920
|
$20,892,941 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.66%
|
190,940
|
$20,571,876 | — | 30 Sep 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.64%
|
183,067
|
$19,723,837 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.61%
|
176,503
|
$19,016,433 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.57%
|
164,545
|
$17,728,078 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.57%
|
162,749
|
$17,534,556 | — | 30 Sep 2025 | |
| Blackstone Tactical Opportunities Fund - FD L.P. |
3/4/5
|
10%+ Owner |
0.35%
|
100,000
|
$16,752,000 | — | 22 Jul 2021 | |
| UBS Group AG |
13F
|
Company |
—
mixed-class rows
|
150,166
mixed-class rows
|
$16,138,308 | — | 30 Sep 2025 | |
| Jason Ryan |
3/4/5
|
Director |
0.4%
|
115,188
|
$14,971,290 | -$4,995,801 | 27 Aug 2025 |
Institutional Holders of GeneDx Holdings Corp. - Common Stock (WGS) as of Q4 2025
As of 31 Dec 2025,
GeneDx Holdings Corp. - Common Stock (WGS) was held by
284 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,993,264 shares.
The largest 10 holders included
Corvex Management LP, Casdin Capital, LLC, BlackRock, Inc., GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, WESTFIELD CAPITAL MANAGEMENT CO LP, SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC, ORACLE INVESTMENT MANAGEMENT INC, and FMR LLC.
This page lists
284
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
265
Q4 2025 holders
284
Holder diff
19
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.